NCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
RECORDATI GROUP
Saint John's Cancer Institute
Novartis
Novartis
Federico II University
Federico II University